相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices
Rafael Paternostro et al.
DIGESTIVE AND LIVER DISEASE (2022)
Baveno VII - Renewing consensus in portal hypertension
Roberto de Franchis et al.
JOURNAL OF HEPATOLOGY (2022)
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death
Mathias Jachs et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease
Benedikt Simbrunner et al.
LIVER INTERNATIONAL (2022)
Portal hypertension is a key determinant of the risk for liver-related events in non-alcoholic fatty liver disease
Rafael Paternostro et al.
JOURNAL OF HEPATOLOGY (2022)
Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis
Benedikt S. Hofer et al.
HEPATOLOGY COMMUNICATIONS (2022)
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
Dalila Costa et al.
JOURNAL OF HEPATOLOGY (2021)
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes
Mathias Jachs et al.
GUT (2021)
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction
Patricia Palau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers A Tailored Approach
Mathias Jachs et al.
CLINICS IN LIVER DISEASE (2021)
Prevention of First Decompensation in Advanced Chronic Liver Disease
Mattias Mandorfer et al.
CLINICS IN LIVER DISEASE (2021)
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
Husam M. Salah et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Thomas Reiberger et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)
Beta-blockers in cirrhosis: Evidence-based indications and limitations
Susana G. Rodrigues et al.
JHEP REPORTS (2020)
Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta-analysis
Mayank Sharma et al.
HEPATOLOGY (2019)
Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis
Wai Gin Lee et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Candid Villanueva et al.
LANCET (2019)
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Sotirios Tsalamandris et al.
EUROPEAN CARDIOLOGY REVIEW (2019)
Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study
R. Schwarzer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity
M. Mandorfer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF HEPATOLOGY (2018)
Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites
Tammo L. Tergast et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography
D. J. Harman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Effects of an Intensive Lifestyle Intervention Program on Portal Hypertension in Patients With Cirrhosis and Obesity: The SportDiet Study
Annalisa Berzigotti et al.
HEPATOLOGY (2017)
Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study
Ting-Shuo Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
Thomas Reiberger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2017)
A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis
Sang G. Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Diabetes mellitus in patients with cirrhosis: clinical implications and management
Laure Elkrief et al.
LIVER INTERNATIONAL (2016)
Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient
Arnulf Ferlitsch et al.
LIVER INTERNATIONAL (2015)
Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis C Patients With New-Onset Diabetes: A Nationwide Cohort Study
Yi-Wen Huang et al.
HEPATOLOGY (2014)
Diabetes Mellitus Is an Independent Prognostic Factor for Major Liver-Related Outcomes in Patients With Cirrhosis and Chronic Hepatitis C
Laure Elkrief et al.
HEPATOLOGY (2014)
Impact of obesity and insulin-resistance on cirrhosis and portal hypertension
Annalisa Berzigotti et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2013)
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
Thomas Reiberger et al.
GUT (2013)
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
Thomas Reiberger et al.
JOURNAL OF HEPATOLOGY (2013)
Obesity Is an Independent Risk Factor for Clinical Decompensation in Patients with Cirrhosis
Annalisa Berzigotti et al.
HEPATOLOGY (2011)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
分享论文
